Influence of papain in biofilm formed by methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus haemolyticus isolates by Oliveira, Hanna Lara da Cruz Dinéas de et al.
*Correspondence: L. A. Teixeira. Departamento Tecnologia Farmacêutica, 
Faculdade de Farmácia, Universidade Federal Fluminense. Rua Mário Viana, 
523 - Santa Rosa, 24241-002 – Niterói – RJ, Brasil. E-mail: tlenise@hotmail.com
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 50, n. 2, apr./jun., 2014
http://dx.doi.org/10.1590/S1984-82502014000200005
Influence of papain in biofilm formed by methicillin-resistant 
Staphylococcus epidermidis and methicillin-resistant 
Staphylococcus haemolyticus isolates
Hanna Lara da Cruz Dinéas de Oliveira1, Maria Emília Castro Kling Fleming1,  
Patrícia Vollu Silva1, Geraldo Renato de Paula1, Débora Omena Futuro1, Guillermo Coca Velarde2, 
Luciana Maria Ramires Esper1, Lenise Arneiro Teixeira1,*
1Faculty of Pharmacy, Federal Fluminense University, Niterói, RJ, Brazil, 2Institute of Mathematics and Statistics,  
Federal Fluminense University, Niterói, RJ, Brazil
Methicillin-resistant Staphylococcus epidermidis (MRSE) and methicillin-resistant Staphylococcus 
haemolyticus (MRSHa) are important coagulase-negative staphylococci. They are often isolated from 
bacteremia in humans mainly due to their ability to form biofilm on the surfaces of medical devices. 
Papain is a complex mixture of proteolytic enzymes and peroxidases extracted from the latex of Carica 
papaya and it is recognized by accelerating the healing process of wounds. This study aimed to evaluate 
the ability of the MRSE and MRSHa isolates to produce biofilms. Besides this, the ability of papain to 
inhibit the formation of biofilms or to disrupt the ones already formed by those bacteria was analyzed. 
Thirty MRSHa and 30 MRSE were isolated from bacteremia and used in this study. It was observed 
that papain has ability to reduce biofilms formed by MRSE (p < 0.06) and by MRSHa (p = 0.0005). In 
addition, papain was able to disrupt mature biofilms made by MRSE (p = 0.014). No antibacterial activity 
of papain was observed for any isolates of MRSE and MRSHa tested. Papain has been demonstrated as 
a potential product for reducing biofilm.
Uniterms: Staphylococcus epidermidis/methicillin-resistant. Staphylococcus haemolyticus/methicillin-
resistant. Biofilm/production. Papain/reducing biofilm.
Staphylococcus epidermidis resistente à meticilina (MRSE) e Staphylococcus haemolyticus resistente 
à meticilina (MRSHa) são importantes estafilococos coagulase negativa. São frequentemente isolados 
em bacteremia humana, principalmente devido à capacidade de formar biofilmes nas superfícies de 
dispositivos médicos introduzidos no organismo. A papaína é mistura complexa de enzimas proteolíticas 
e peroxidases extraídas do látex de Carica papaya, reconhecida por acelerar os processos de cura de 
feridas. Este estudo teve como objetivo avaliar a capacidade dos MRSE e MRSHa em produzir biofilmes 
e analisar a capacidade da papaína em inibir a formação de biofilme ou desintegrar biofilmes já formados 
por essas bactérias. Observou-se que a papaína tem capacidade de reduzir a formação de biofilme por 
MRSE (p < 0,06) e MRSHa (p = 0,0005). Além disso, a papaína foi capaz de desintegrar biofilme maduro 
formado por MRSE (p = 0,014). Nenhuma atividade antibacteriana da papaína foi observada para qualquer 
das duas espécies de bactérias testadas. A papaína mostrou-se produto potencial para reduzir biofilme.
Unitermos: Papaína. Staphylococcus epidermidis/resistente à meticilina. Staphylococcus haemolyticus/
resistente à meticilina. Biofilme/produção. Papaína/redução de biofilme.
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INTRODUCTION
Coagulase-negative staphylococci, especially 
Staphylococcus epidermidis followed by Staphylococcus 
haemolyticus, have been frequently reported as significant 
etiological agents that cause nosocomial infections (Keim 
et al., 2011, Kristóf et al., 2011; Rosado, Romanelli, 
Camargos, 2011). The most important property of these 
staphylococci is their capability to form biofilm on the 
surfaces of foreign bodies introduced into the organism 
(Donlan, 2011; Sander et al., 2012). The infections are 
mainly caused by strains that have already colonized parts 
of the human body, making the colonized person a reservoir 
that will spread the organisms (Saising et al., 2012).
In biofilms, these organisms are involved in a matrix 
composed of polysaccharides, proteins, and extracellular 
DNA, which provides protection against antimicrobial 
products and immune system (Von Eiff, Heilmann, 
Peters, 1999; MacCann et al., 2008). The process of 
biofilm production has not been totally clarified yet, but 
in S. epidermidis, it seems to occur in two important steps: 
adherence to the inert surface and biofilm accumulation 
(Götz, 2002). Many bacterial products are thought to 
be involved in the initial phase of bacterial adherence, 
including the Atl and Aap proteins, teichoic acid and 
staphylococcal adhesins, proteins, which play an important 
role in the plasma-coated biomaterial. In the second 
phase, the bacteria attach to the surface of the polymer 
produce and accumulate an extracellular, amorphous, and 
mucoid polysaccharide material named biofilm (Von Eiff, 
Heilmann, Peters, 2002). Studies have indicated that the 
mature biofilm facilitates colonization and persistence of 
bacteria in the host (Götz, 2002). In S. epidermidis, the ica 
operon (encoding enzymes that are involved in biosynthesis 
of polysaccharide intercellular adhesin; PIA) seems to be 
essential for the production of biofilm (Araujo et al., 2006).
Papain is a complex mixture of proteolytic enzymes 
and peroxidases extracted from the papaya latex of Carica 
papaya. It has been used in Brazil since 1983 to treat 
wounds (Leite et al., 2012). Several studies have recognized 
that papain accelerates wound healing processes, especially 
chronic ones. It can be used in different concentrations 
according to the type of the wounded tissue (Leite et al., 
2012). The treatment of wounds and burns occurs due to 
papain debriding and anti-inflammatory action (Monetta, 
1987; Silva et al., 2007, Chukwuemeka, Anthoni, 2010). 
Because of antitrypsin α-1, an antiprotease that inhibits the 
action of enzymes in healthy tissues, papain can be safely 
used in skin without damages (Flindt, 1979). Further, 
proteolysis in necrotic tissues and cell fragments from a 
wound aid the healing process (Sanchez Neto et al., 1993; 
Leite et al., 2012). In addition, biofilms can also be found 
in wounds, which makes the treatment more difficult and 
increases wound bioburden (Kim, Steinberg, 2012; Percival 
et al., 2012; Dowd, 2008). Moreover, previous experimental 
and clinical data have recommended using papain to reduce 
wound bioburden and to promote wound healing (Payne et 
al., 2008). 
Although bactericidal activity of papain has been 
reported for gram-positive and gram-negative organisms 
(Dawkins et al., 2003; Chukwuemeka, Anthoni, 2010; 
Bhardwaj, Ballal, Velmurugan, 2012), there is no consensus 
about this function. Ferreira et al. (2008) found this activity 
for Staphylococcus aureus and Pseudomonas aeruginosa 
only in 10% of papain. However, Lima et al. (2009) verified 
that papain has no antibacterial activity for Enterococcus 
faecalis, P. aeruginosa, S. aureus, Klebsiella pneumoniae, 
and Salmonella typhi in different concentrations.
Considering the proteolytic characteristic described 
for papain and the biopolymer matrix composition of 
bacterial biofilms, this study aimed to evaluate the ability 
of papain to act as an inhibitor of biofilms in different 
concentrations. Moreover, given the disagreement of 
reports analyzed, we also evaluated the antibacterial 
activity of the papain.
MATERIAL AND METHODS
Bacterial strains
To evaluate whether papain had the capacity to 
interfere in staphylococcal biofilm, 60 hospital isolates 
(30 methicillin-resistant Staphylococcus epidermidis- 
MRSE and 30 methicillin-resistant Staphylococcus 
haemolyticus-MRSHa) were analyzed. After that, 78 
more isolates (53 MRSE and 25 MRSHa) were included 
to determine the minimal inhibitory concentration. The 
isolates were collected from bloodstream infection and 
were previously identified as oxacillin resistance. All 
bacteria were preserved at -20 ºC at 10% glycerol stock 
on Tryptic soy broth (TSB).
Papain solution
Papain (Prozyn, Brazil) was solubilized in water 
Milli-Q sterilized to appropriate dilutions and kept in 
refrigerated for 7 days.
Biofilms assay
The biofilm formation was induced by TSB 
supplemented with 1% glucose (TSB+G) and was formed on 
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inert polystyrene surfaces (96-well microtitre plates, Nuclon; 
NalgeNunc International, Roskilde, Denmark) as described 
by Araújo et al. (2006). Staphylococcus epidermidis 70D 
(strong biofilm producer) and Streptococcus pyogenes ATCC 
75194 (biofilm non-producer) were used as positive and 
negative controls, respectively. The microtitre plates were 
incubated for 20 h at 36 ± 1 ºC. The optical density (OD) of 
the stained biofilm was measured at 560 nm using a microtitre 
plate reader. The isolates were classified according to Amaral 
et al. (2006) as follows: biofilm non-producers (BU ≤ 0.182), 
weak biofilm producers (0.182 < BU ≤ 0.364), moderate 
biofilm producers (0.364 < BU ≤ 0.728), and strong biofilm 
producers (BU > 0.728).
Effect on bacteria attachment assay
To determine whether papain directly inhibited 
attachment of the bacteria to the polystyrene, MRSE and 
MRSHa isolates were grown for 20 h in TSB+G medium 
in the presence or absence of 2.5% or 5% of papain added 
to well polystyrene microtitre plates (Nuclon; NalgeNunc 
International, Roskilde, Denmark), followed by staining 
with crystal violet (Araujo et al., 2006).
Effect on preformed biofilm assay
We investigated whether papain could affect 
preformed biofilm produced by 11 MRSE and 11 MRSHa. 
Thus, after biofilm was established, 2.5% of papain were 
added to well polystyrene microtitre plates and incubated 
for 20 hours at 36 ± 1 ºC. After the treatment, the wells 
were gently washed and stained with violet crystal as 
described (Araujo et al., 2006).
In all biofilm experiments, each isolate was 
performed at least twice.
Scanning with inverted microscopy
Biofilms formatted on the polystyrene microtitre 
plates were analyzed in 10 isolates (5 MRSE and 5 
MRSHa) by scanning microscopy (Nikon Eclipse TE 
2000-U model), in order to control the results of the 
spectrophotometric test. At least five different microscopy 
fields of each isolate were examined.
Determination of minimal inhibitory 
concentration (MIC)
The MIC values were determined by the agar 
dilution method standardized by the Clinical and 
Laboratory Standards Institute (CLSI, 2011). Papain 
was incorporated into the Muller Hinton Agar medium 
(Difco, Laboratories, USA). Each plate contained different 
concentrations of papain (1%, 2.5%, 5%, and 10%; Prozyn, 
São Paulo, Brazil). The bacterial suspensions containing 
approximately 107 CFU/mL were inoculated onto agar 
plates using a Steers replicator. The final inoculum on the 
agar was 104 CFU per spot.
Staphylococcus  aureus  ATCC 6538P and 
Staphylococcus epidermidis ATCC 12228 were used 
as microorganisms control, and drug-free plates were 
prepared and used as growth controls. After incubation 
for 24 h at 37 °C, the lowest concentration of the products 
able to inhibit bacterial growth was considered the MIC.
Statistical analysis
The null hypothesis using Student’s t test, for a 
significance level of 0.1, was performed either for the 
analyses of the effect of papain on biofilm formation or 
biofilm disruption.
RESULTS AND DISCUSSION
Biofilm study
Biofilms is the most important virulent factor for 
coagulase-negative staphylococci. Our data showed that 
16 (53.3%) of MRSE were able to form biofilm and 17% 
of them displayed high ability to form biofilm (Table I). 
Previous study realized with isolates in the same hospital 
showed similar results (Araújo et al., 2006). In relation to 
MRSHa, 21 (70%) isolates were able to produce biofilm, 
of which 26.6% of them were classified to be a strong 
biofilm producer (Table I). Similar to our results, Fredheim 
et al. (2009) found that 74% of the S. haemolyticus 
analyzed were able to produce biofilms. However, the 
biofilm formed by S. haemolyticus has not been subject 
to more detailed studies so far.
TABLE I-  Biofilm formation of methicillin-resistant 
Staphylococcus epidermidis (MRSE) and methicillin-resistant 
Staphylococcus haemolyticus (MRSHa)
Biofilm
Microorganism (%)
MRSE MRSHa
Strong 5 (16.6%) 8 (26.7%)
Moderate 6 (20.1%) 5 (16.7%)
Weak 5 (16.6%) 8 (26.7%)
Total producer 16 (53.3%) 21 (70%)
Non-producer 14 (46.7%) 9 (30%)
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Because staphylococci are among the most likely, 
microorganisms to contaminate and adhere to any 
medical device that penetrates host surfaces (Vuong, 
Otto, 2002), several compounds have been tested as 
biofilm inhibitors, and some are already used to coat 
catheters (Huigens et al., 2009; Juda et al., 2008, Maki 
et al., 1997). Randomized trials have shown the benefits 
of using antibiotic-impregnated catheters in hospitalized 
patients to reduce bacterial colonization on the surface of 
these devices (Maki et al., 1997). In this paper, we explore 
the effect of different concentrations of papain (2.5% or 
5%) in biofilm production by several MRSE and MRSHa 
isolates. When papain (2.5% or 5%) was incorporated 
into the culture, the biofilm formation by MRSE was 
inhibited (p = 0.06). However, the papain action showed 
to be more effective for MRSHa isolates (p = 0.0005). 
The experiment suggested that papain is able to influence 
the ability of cells to form biofilm, thus affecting the 
bacterial attachment. Scanning with inverted microscopy 
is presented in Figure 1.
It is well known that staphylococcal biofilm 
formation is multi-factorial and two major enzymes, 
accumulation-associated protein (Aap) and autolysin 
(Atl), seem to be associated with the first step of biofilm 
formation (Biswas et al., 2006). In S. epidermidis, PIA 
production and protein factors (i.e., Aap and AtlE) 
likely contribute strongly to the development of mature 
biofilms in vivo in some isolates (Stevens et al. 2009). 
In their article, it was verified that sodium metaperiodate 
caused a significant decrease in biofilm formed by PIA 
and proteinase K treatment was sufficient to significantly 
disperse the biofilm matrix, suggesting a role for protein 
in biofilm production. Autolysins such as AtlE play an 
important role in cell-wall processing and recycling, and 
it is interesting to speculate that the major role they have 
in the process of biofilm formation may be to orientate 
and expose cell-surface adhesins correctly in order to 
maximize and ensure an effective interaction with either 
host factors or device surfaces (Stevens et al., 2009).
Karamanos et al. (1995) reported that the extracellular 
slime layer of Staphylococcus epidermidis ATCC 35983 
contains two non-anionic carbohydrate-containing 
proteins degradable by papain, and a macromolecule 
also degradable by papain-bearing acidic carbohydrates 
covalently bound to protein. Although we did not test 
the hypothesis in which papain can damage AtlE, it is 
reasonable to suppose that papain can degrade these 
biofilm-associated proteins and/or another protein(s) 
involved in biofilm formation.
On the other hand, to verify whether papain also 
disrupted the biofilm that accumulated on the polystyrene 
surface, 22 isolates (11 MRSE and 11 MRSHa) were 
used. Thus, preformed biofilms were treated with 2.5% 
papain and incubated for 20 hours at 36 °C±1 ºC. The data 
obtained for the MRSHa isolates showed no significant 
influence of the enzyme on biological films (p = 0.573) 
(Figure 2A). However, the results showed a huge reduction 
of the optical densities obtained for MRSE isolates treated 
with papain compared to the untreated ones (Figure 2B), 
FIGURE 1 - Inverted microscope of biofilm produced by a 
MRSHa representative isolate on polystyrene surface. (A) 
Untreated, (B) 5% papain, and (C) 2.5% papain. Increased 40x.
FIGURE 2 – Boxplot of optical densities of biofilms formed by staphylococcal isolates, both untreated and those treated with 2.5% 
of papain for a period of 20 hours. (A) Staphylococcus haemolyticus – MRSHa, (B) Staphylococcus epidermis – MRSE.
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with a significance level p = 0.014. For Orgaz et al. (2011), 
diverse results against different bacteria may be the 
consequence of specific features of their biofilm matrix, 
cell wall or membrane, and/or some intracellular events.
Previous studies have suggested that extracellular 
proteins seem to be one of the main components of the 
biofilm matrix formed by S. haemolyticus (Fredheim et 
al., 2009; Silva et al., 2013). Because of that, we expected 
papain to disrupt biofilm accumulation produced by 
MRSHa. In the present study, papain disintegrated better 
biofilm formed by MRSE, the principal component of 
which is poly-β-1,6-N-acetyl-D-glucosamine (PNAG), 
also known as polysaccharide intercellular adhesin (Götz, 
2002). According to Jabbouri and Sadovskaya (2010), 
the sensitivity of staphylococcal biofilms to enzymatic 
treatments depends on their chemical composition. The 
authors report that protein components in biofilms play 
an important role in stabilizing intercellular structure. 
Our results demonstrate that more studies are still needed 
to define the roles and the other components of biofilms 
formed by staphylococci bacteria.
Determination of minimal inhibitory 
concentration (MIC)
Papain is a safe agent to use in wounds with high-
level bacteria because it is able to reduce bioburden (Payne 
et al., 2008). Thus, we determined the anti-staphylococcal 
activity of this agent. Six isolates tested showed no 
susceptibility for 1%, 2.5%, 5%, or 10% papain. To 
confirm this result, we decided to add 78 more isolates; 
hence, all 138 bacteria analyzed demonstrated no activity 
to papain at different concentrations.
Several studies reported papain antibacterial 
activity in gram-positive and gram-negative bacteria 
(Chukwuemeka, Anthoni, 2010; Bhardwaj, Ballal, 
Velmurugan, 2012). Nonetheless, Ferreira et al. (2008) 
verified that only papain gel 10% was able to inhibit S. 
aureus. Notably, Lima et al. (2009) did not find antibacterial 
activity of papain for various microorganisms. As shown in 
our study. Seenivasan et al. (2010) reported that papain has 
interacted with the bacterial cell membrane, destabilizing it 
and resulting in osmotic shock and release of cytoplasmic 
contents, where the antibacterial activity was established. 
However, in vivo, the association between papain and 
the reduction of infections observed in the wound seems 
to be due its anti-inflammatory action, which promotes 
cellular reproduction, stimulates cytokines production, and 
recruits phagocytic cells, so that the environment becomes 
unfavorable for the growth of pathogenic microorganisms 
(Falanga, 2002; Lima et al., 2009).
CONCLUSION
Papain seems to be a promising breakthrough in the 
prevention and disruption of biofilms, a subject of interest 
of the pharmaceutical industry. Although our experiments 
showed that papain has no bactericidal activity against 
Staphylococcus epidermidis  and Staphylococcus 
haemolyticus, it presented a potential product that may 
reduce biofilm formed by these microorganisms.
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